Status:
COMPLETED
MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)
Lead Sponsor:
Organon and Co
Conditions:
Rhinitis Allergic
Eligibility:
All Genders
15-65 years
Phase:
PHASE2
Brief Summary
The clinical study evaluates the efficacy and safety of MK0476 in adult patients with allergic rhinitis.
Eligibility Criteria
Inclusion
- Adult patients with seasonal allergic rhinitis
Exclusion
- Patients who have nasal diseases (e.g., nasal polyp, septonasal arcuation, hypertrophic rhinitis), upper respiratory infection, sinusitis, infectious rhinitis, ocular infection and those disease severe enough to interfere with assessment of effectiveness
- Patients who have rhinitis medicamentosa, or nonallergic rhinitis (e.g., vasomotor rhinitis, eosinophilia rhinitis)
- Patient has a disease of the cardiovascular, hepatic, renal, hematologic systems, or other severe disease
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2004
Estimated Enrollment :
945 Patients enrolled
Trial Details
Trial ID
NCT00446186
Start Date
February 1 2004
End Date
March 1 2004
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.